Navigation Links
Sequent Medical, Inc. Launches VIA Microcatheter
Date:12/11/2012

ALISO VIEJO, Calif., Dec. 11, 2012 /PRNewswire/ -- Sequent Medical, Inc. announced today it has received CE mark for the VIA™ Microcatheter and is initiating commercial introduction of this new product family in select markets.

The VIA will be used for delivery and deployment of Sequent's WEB® Aneurysm Embolization System, which is utilized to treat cerebral aneurysms. The VIA is currently available in two models, the VIA and the VIA PLUS.

"The VIA Microcatheter provides an optimal combination of properties for stable WEB placement, retrieval and navigability and will enable physicians to treat a broader range of aneurysm with the WEB," said PD Dr. med. Werner Weber, Head of the Department of Radiology and Interventional Neuroradiology, Klinikum Vest, Knappschaftskrankenhaus, Recklinghausen, Germany.

"Combined with planned additions to our WEB platform, the VIA demonstrates Sequent Medical's ongoing commitment to developing a broad portfolio of innovative catheter-based technologies for neurovascular specialists and their patients," said Tom Wilder, President and Chief Executive Officer. 

About Sequent Medical, Inc.

Sequent Medical, Inc. (www.sequentmedical.com) is a privately held medical-device company that is dedicated to the development of innovative catheter-based neurovascular technologies.  The WEB Aneurysm Embolization System and VIA Microcatheter have both received the CE mark.  They are not available for sale or use in the United States.  Sequent Medical, Inc. is headquartered in Aliso Viejo, California, and has European operations based in Bonn, Germany.

About The WEB Aneurysm Embolization System

Building upon the foundation of endovascular embolic coils, the WEB is a low porosity intrasaccular neurovascular embolization device that is designed to bridge the neck of a ruptured or unruptured intracranial aneurysm and to promote rapid, peri-procedural stasis. The WEB enables physicians to treat intracranial aneurysms with the familiarity of an intrasaccular approach while using established biomaterials.  


'/>"/>
SOURCE Sequent Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
2. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
3. Barrack, Rodos & Bacine Files Class Action Lawsuit Against St. Jude Medical, Inc.
4. Nonin Medical, Inc. arbeitet bei Pulsoxymetrieangebot für 2net-Plattform für drahtlose Gesundheitslösungen mit Qualcomm Life zusammen
5. Nonin Medical, Inc. Collaborates with Qualcomm Life to Provide Pulse Oximetry for the 2net Platform for Wireless Health Solutions
6. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
7. Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
8. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
9. Boston Scientific to Acquire BridgePoint Medical, Inc.
10. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
11. Solta Medical, Inc. Closes Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):